This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Tech That Disrupts Our Lives for the Better

NEW YORK ( TheStreet) -- For many, it's difficult to go a day without checking Facebook (FB) or reading the latest posts on a favorite blog or pinning a cool picture. Today, losing your smartphone is just as bad as losing your car keys.

It was pretty much the same a decade ago. Only the names have changed. We checked AOL (AOL - Get Report), read the newspaper, emailed photos and lost cellphones.

Many products and companies we once relied on daily have pretty much vanished (also see Life-Changing Tech's Fall From Glory). Some, like Apple (AAPL), Google (GOOG) and (AMZN - Get Report) continue to grab our attention and have us wanting to try something new. Others are waiting to emerge.

So who or what is leading the way? That, of course, is anyone's educated guess. But here are some companies and markets to remember.

Self-Diagnosis Kits

Already you can choose from multiple mobile apps to figure out what that weird growth is on your toe or what the sound of your cough indicates. As for accuracy? Most apps add the education-only disclaimer. The trend toward a more accurate, home-based self diagnosis is gaining momentum in order to combat rising medical costs and health insurance rates.

Last year, the U.S. Food and Drug Administration approved the first rapid, take-home HIV test, the OraQuick In-Home HIV Test from OraSure Technologies (OSUR - Get Report). The $40 kit produces a result within 40 minutes. Mode Diagnostics in the U.K. is hoping to soon start selling a self-testing colon-cancer kit. It's not that we won't need doctors anymore but it's about the availability of affordable self-testing kits combined with better communication that could speed up or eliminate actual doctor visits and lower our medical costs.

Genetic testing

Now that the human genome has been mapped, figuring out what sort of good and bad traits are carried by a person's DNA is already being used to combat potential health issues. One University of California research team is studying test kits from Genomic Health (GHDX - Get Report) to see if genetic testing could prevent overtreatment of prostate cancer by gauging its aggressiveness. As prices drop, genetic testing will become more accessible and help predict future health issues.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AOL $38.91 -0.66%
AMZN $367.35 -0.97%
GHDX $29.60 -3.50%
NFLX $418.26 -0.83%
OSUR $6.48 3.10%


DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs